• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·BNRUDY.BO
Share

BNR Udyog Limited Stocks

₹ 36.59Last Updated 21.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

₹ 1.03M

₹ 36.59
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

BNR Udyog Limited delivers a diverse range of services, primarily focusing on investment, business support, and medical transcription. The company's service offerings further encompass e-governance solutions, healthcare provision, software development, system integration, robust database management, data processing, and even construction projects. Its operational structure is segmented into Medical Transcription, Business Support Services, and Finance and Other Activities. Badri Narayan Rathi established the firm on November 29, 1994, and its corporate headquarters are located in Hyderabad, India.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.10.2026 08:00

L'Oréal's sales exceeded expectations. Has high-end cosmetics proven to be more resilient than luxury goods?

23.10.2026 07:00

French sovereign risk premium has hit eurozone crisis levels

23.10.2026 05:07

Cybersecurity stocks are rising due to a new threat. Which ones aren't too late to buy?

23.10.2026 01:52

Nasdaq plunges, Wall Street’s fear gauge jumps 15% as investors flee tech

23.10.2026 00:09

Moderna plunges 25% as leaked cancer vaccine data falls short of lofty expectations

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026